Bank Mandiri Persero Tbk vs Prodia Diagnostic Line Tbk — how do they compare? Bank Mandiri Persero Tbk trades at Rp4,130 (market cap 381.61T, 108.71M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Bank Mandiri Persero Tbk is far larger — about 810.9× Prodia Diagnostic Line Tbk's market cap, and Bank Mandiri Persero Tbk is more actively traded (108.71M versus 28.43M). Which is the better fit depends on your goals.
| BMRI | PRDL | |
|---|---|---|
Market Cap | 381.61T | 470.58B |
Volume | 108.71M | 28.43M |
Lot | 1.09M | 284.34K |
Turnover | 447.18B | 7.8B |
Average Price | 4,113.54 | 274.19 |
Value | 447.18B | 7.8B |
Indicative Equilibrium Price | 4,130 | 270 |
Indicative Equilibrium Volume | 185.32K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Read more on BMRI →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →